SUNPHARMA.BO

Sun Pharmaceutical Industries Limited · Healthcare · Drug Manufacturers - Specialty & Generic

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$45.68B

PE Ratio

40.1

EV to Ebitda

—

Earnings Yield

2.00%

Revenue (TTM)

$5.93B

Net Income (TTM)

$1.14B

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

14.00%

Profit Margin

19.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$45.68B

Revenue TTM$5.93B

Shares Outstanding2.40B

Float1019857151

Insider Ownership56.00%

Institutional Ownership27.00%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)14.00%

Rev Growth Est 1Y Forward0.11

EPS Growth (Quarterly YoY)16.00%

EPS Growth Est Quarterly12.73

LT EPS Growth Estimates12.00%

Operations16 fields›

Revenue TTM$5.93B

Gross Margin TTM79.00%

Gross Margin (Quarterly)81.00%

Operating Margin TTM26.00%

Operating Margin (Quarterly)23.00%

Operating Expenses TTM$26.5M

Profit Margin TTM19.00%

Profit Margin (Quarterly)22.00%

Net Income TTM$1.14B

EPS TTM45.5

EPS (Quarterly)14.04

EBITDA Margin TTM28.00%

EBITDA TTM$1.67B

Capex % of Revenue TTM8.00%

Capital Expenditures$471.9M

FCF % of Revenue (Quarterly)21.00%

Efficiency1 fields›

ROA9.00%

Valuation8 fields›

P/E (TTM)40.1

P/E Forward27.93

PEG1.04

EV/Revenues (TTM)7.37

Price To Book5.62

Price to Tangible Book7.98

Earnings Yield2.00%

Payout Ratio41.00%

Liquidity9 fields›

Cash Per Share104.33

Current Ratio2.89

Cash & ST Assets$122.57B

Goodwill & Intangibles$229637.90T

Total Assets$10.83B

Total Liabilities$8.11B

Shareholders Equity$8.13B

Interest Expense$26.5M

Goodwill % of Assets22143058.00%

Yields3 fields›

Payout Ratio41.00%

Earnings Yield2.00%

Buyback Yield0.00%